357 related articles for article (PubMed ID: 27462980)
1. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
2. MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management.
Morcillo MÁ; García de Lucas Á; Oteo M; Romero E; Magro N; Ibáñez M; Martínez A; Garaulet G; Arroyo AG; López-Casas PP; Hidalgo M; Mulero F; Martínez-Torrecuadrada J
Contrast Media Mol Imaging; 2018; 2018():8382148. PubMed ID: 30224904
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
[TBL] [Abstract][Full Text] [Related]
4. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
5. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
Shimizu Y; Temma T; Sano K; Ono M; Saji H
Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunodetection of membrane type-1 matrix metalloproteinase relevant to tumor malignancy with a pre-targeting method.
Sano K; Temma T; Kuge Y; Kudo T; Kamihashi J; Zhao S; Saji H
Biol Pharm Bull; 2010; 33(9):1589-95. PubMed ID: 20823579
[TBL] [Abstract][Full Text] [Related]
7. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
8. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
[TBL] [Abstract][Full Text] [Related]
9. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
10. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
Holland JP; Divilov V; Bander NH; Smith-Jones PM; Larson SM; Lewis JS
J Nucl Med; 2010 Aug; 51(8):1293-300. PubMed ID: 20660376
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
Kondo N; Temma T; Shimizu Y; Ono M; Saji H
Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
[TBL] [Abstract][Full Text] [Related]
12. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers.
Kondo N; Temma T; Shimizu Y; Watanabe H; Higano K; Takagi Y; Ono M; Saji H
Cancer Sci; 2013 Apr; 104(4):495-501. PubMed ID: 23305265
[TBL] [Abstract][Full Text] [Related]
13. Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors.
Temma T; Sano K; Kuge Y; Kamihashi J; Takai N; Ogawa Y; Saji H
Biol Pharm Bull; 2009 Jul; 32(7):1272-7. PubMed ID: 19571397
[TBL] [Abstract][Full Text] [Related]
14. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
15. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and
Pringle TA; Chan CD; Luli S; Blair HJ; Rankin KS; Knight JC
Bioconjug Chem; 2022 Aug; 33(8):1564-1573. PubMed ID: 35867034
[TBL] [Abstract][Full Text] [Related]
17. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
18. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS
J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
[TBL] [Abstract][Full Text] [Related]
19. ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts.
Cheal SM; Ruan S; Veach DR; Longo VA; Punzalan BJ; Wu J; Fung EK; Kelly MP; Kirshner JR; Giurleo JT; Ehrlich G; Han AQ; Thurston G; Olson WC; Zanzonico PB; Larson SM; Carrasquillo JA
Mol Pharm; 2018 Jun; 15(6):2133-2141. PubMed ID: 29684277
[TBL] [Abstract][Full Text] [Related]
20. Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.
Pratt J; Iddir M; Bourgault S; Annabi B
Mol Carcinog; 2016 Feb; 55(2):148-60. PubMed ID: 25640948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]